• Citer

Factors associated with therapeutic response to adalimumab in hidradenitis suppurativa: evidence from the Belgian patients of the European Registry for Hidradenitis Suppurativa (ERHS-Be).

par Daoud, Mathieu ;Benhadou, Farida ;Suppa, Mariano ;Sarkis, Anne-Sophie ;Heudens, Stéphanie ;Desmarest, Lila ;Njimi, Hassane ;Daxhelet, Mathilde ;Nobile, Laura LN;Karama, Jalila ;White, Jonathan Michael J.M.L.;Jemec, Gregor B E;Del Marmol, Véronique
Référence Archives of dermatological research, 317, 1, page (189)
Publication Publié, 2025-01-01

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Factors associated with therapeutic response to adalimumab in hidradenitis suppurativa: evidence from the Belgian patients of the European Registry for Hidradenitis Suppurativa (ERHS-Be).
Auteur:	Daoud, Mathieu; Benhadou, Farida; Suppa, Mariano; Sarkis, Anne-Sophie; Heudens, Stéphanie; Desmarest, Lila; Njimi, Hassane; Daxhelet, Mathilde; Nobile, Laura LN; Karama, Jalila; White, Jonathan Michael J.M.L.; Jemec, Gregor B E; Del Marmol, Véronique
Informations sur la publication:	Archives of dermatological research, 317, 1, page (189)
Statut de publication:	Publié, 2025-01-01
Sujet CREF:	Dermatologie
Mots-clés:	Adalimumab
	Hidradenitis suppurativa
	Outcome
	Personalised medicine
	Predictor
	Scoring
MeSH keywords:	Humans
	Hidradenitis Suppurativa -- drug therapy
	Adalimumab -- therapeutic use
	Male
	Female
	Adult
	Belgium -- epidemiology
	Registries -- statistics & numerical data
	Retrospective Studies
	Severity of Illness Index
	Treatment Outcome
	Middle Aged
	Young Adult
	Phenotype
	Anti-Inflammatory Agents -- therapeutic use
Langue:	Anglais
Identificateurs:	urn:issn:0340-3696
	info:doi/10.1007/s00403-024-03675-w
	info:pii/10.1007/s00403-024-03675-w
	info:pmid/39775946